Onward Medical N.V.
ONWRY·OTC Markets OTCQX
2.6400−0.4200 (−13.73%)today
As of Oct 30, 3:00 PM EST · May be delayed up to 15 min · USD
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close3.0600
Open2.6400
Day range—
52-week range2.52005.7600
Off day high0.00%
Off 52-week high−54.17%
Volume100
Avg. volume (3M)1.95K
Market cap—
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.81
Shares outstanding—
Short interest—
Earnings dateApr 1, 2025
Analyst target—
Profit margin0.00%
Against its peers
Compare in full ›| ONWRY | LFWD | ATEC | TCMD | NSPR | BVS | |
|---|---|---|---|---|---|---|
| Market cap | — | 17.16M | 1.27B | 608.87M | 36.31M | 781.98M |
| P/E (TTM) | — | — | — | 26.4 | — | 14.1 |
| Forward P/E | — | -7.0 | 14.7 | 18.5 | -1.6 | 12.5 |
| Price/book | 2.3 | 1.4 | -552.0 | 2.7 | 1.2 | 3.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −39.04% | −5.08% | −57.56% | +13.87% | −60.20% | +52.67% |
| Today | −13.73% | +3.95% | +10.84% | +9.69% | +20.47% | +4.34% |
The closest companies by business. Prices may be delayed up to 15 min.
Latest news
All ONWRY news ›ONWARD Medical Announces the Appointment of Fouad Azzam to its Board of Directors
Fouad Azzam is a Partner with EQT Life Sciences, bringing extensive experience investing in and supporting fast-growing medical technology and life sciences companies "We are pleased to welcome Fouad Azzam to our Board of Directors,” said…
From the 4Search news index, newest first.
In the news
4mentions in 30 days
4with it in the headline
Positivesentiment
Mentioned with
People in the coverage
Themes
Most coverage from
- manilatimes.net2
- globenewswire.com1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.